Inhibitor Therapeutics's total assets for Q2 2025 were $3.91M, a decrease of -13.26% from the previous quarter. INTI total liabilities were $3.19M for the fiscal quarter, a 1.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.